Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1371 |
Name of the vaccine | NasoShield |
Microbe | Bacteria |
Disease name | Anthrax |
Name of bacteria | Bacillus anthracis |
Type of vaccine | Viral vector |
Nucleic acid content | Linear DNA |
Age | 18 to 49 years |
Description of the vaccine | Adenovirus-vectored anthrax vaccine. |
Name of the manufacturer | Altimmune, Inc. |
Name of the manufacturing country | United States |
Year of manufacture | 2021 |
Clinical Phase status | Clinical - Phase 1 |
Bacterial strain | Gram-positive, rod-shaped bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Single or two doses. |
Mechanism of action | NA |
Route of administration | NA |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Both |
Interspecies transfer | Yes (Zoonotic disease through contact with an infected animal or by inhaling spores) |
PubMed identifier | NA |
Clinical trial number | NCT04415749 |
Reference | NA |
Other name | NA |
Additional Links | NA |